Nothing Special   »   [go: up one dir, main page]

Tsang et al., 2000 - Google Patents

Sputum elastase in steady-state bronchiectasis

Tsang et al., 2000

View PDF
Document ID
10642666780643662604
Author
Tsang K
Zheng L
Ho J
Lam W
Chan K
Ho P
Ooi G
Publication year
Publication venue
Chest

External Links

Snippet

Study objectives To study the correlations between sputum elastase output with clinical and sputum inflammatory and microbial factors in steady-state bronchiectasis. Design Prospective recruitment of patients with bronchiectasis (17 women; 48.5±16.5 years old; …
Continue reading at www.researchgate.net (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis

Similar Documents

Publication Publication Date Title
Tsang et al. Sputum elastase in steady-state bronchiectasis
Tsang et al. Inhaled fluticasone reduces sputum inflammatory indices in severe bronchiectasis
Soler et al. Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease
Hill et al. Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis
Crooks et al. Bronchial inflammation in acute bacterial exacerbations of chronic bronchitis: the role of leukotriene B4
White et al. Chronic obstructive pulmonary disease• 6: the aetiology of exacerbations of chronic obstructive pulmonary disease
Fujimoto et al. Eosinophilic inflammation in the airway is related to glucocorticoid reversibility in patients with pulmonary emphysema
Oishi et al. Role of interleukin-8 (IL-8) and an inhibitory effect of erythromycin on IL-8 release in the airways of patients with chronic airway diseases
Hoover et al. Chronic sinusitis: risk factors for extensive disease
Vignola et al. Increased levels of elastase and α1-antitrypsin in sputum of asthmatic patients
Bergin et al. Airway inflammatory markers in individuals with cystic fibrosis and non-cystic fibrosis bronchiectasis
Boutten et al. Compartmentalized IL-8 and elastase release within the human lung in unilateral pneumonia.
Ordonez et al. Inflammatory and microbiologic markers in induced sputum after intravenous antibiotics in cystic fibrosis
Lucet et al. Outbreak of multiply resistant Enterobacteriaceae in an intensive care unit: epidemiology and risk factors for acquisition
Black et al. Serological evidence of infection with Chlamydia pneumoniae is related to the severity of asthma
Montón et al. Cytokine expression in severe pneumonia: a bronchoalveolar lavage study
Sethi et al. Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease
Armstrong et al. Lower airway inflammation in infants with cystic fibrosis detected by newborn screening
Martínez-García et al. Inhaled steroids improve quality of life in patients with steady-state bronchiectasis
Ordonez et al. Increased neutrophil numbers and IL-8 levels in airway secretions in acute severe asthma: clinical and biologic significance
Ordoñez et al. Effect of clarithromycin on airway obstruction and inflammatory markers in induced sputum in cystic fibrosis: a pilot study
Piitulainen et al. α1-antitrypsin deficiency in 26-year-old subjects: lung, liver, and protease/protease inhibitor studies
Grattendick et al. Alveolar macrophage activation by myeloperoxidase: a model for exacerbation of lung inflammation
Blasi et al. Long-term azithromycin use in patients with chronic obstructive pulmonary disease and tracheostomy
Audebert et al. Viper bites in France: clinical and biological evaluation; kinetics of envenomations